Sign up for Synvisc-One Emails

Please take a few moments to tell us a little about yourself, so we can customize your email with information and special offers of interest to you.

         
 

Our Privacy Promise (Close): We will not rent or sell your information to anyone. Your mailing address, email address and any other personal information you provide voluntarily are kept confidential and will be used only to send you information about osteoarthritis, SYNVISC and Synvisc-One. View our Privacy Policy.


 
 
Which of the following treatments have you received or are you currently receiving for your knee pain?
(Please check all that apply)
 

Hyalgan is a registered trademark of Fidia S.P.A.
Supartz is a registered trademark of Seikugaku
Orthovisc is a registered trademark of Anika Therapeutics Inc.
Euflexxa is a registered trademark of Ferring B.V.

Important Safety Information

Synvisc-One® (hylan G-F 20) and SYNVISC® (hylan G-F 20) are used to relieve knee pain due to osteoarthritis (OA). They are for patients who do not get enough relief from simple painkillers such as acetaminophen, or from exercise and physical therapy.  Synvisc-One and SYNVISC are generally well tolerated. However, they may not work for everyone. The side effects most commonly seen when Synvisc-One or SYNVISC is injected into the knee were pain, swelling and/or fluid buildup in or around the knee. Cases where the swelling is extensive or painful should be discussed with your doctor. Other side effects such as rash have been reported rarely. Before trying Synvisc-One or SYNVISC, tell your doctor if you are allergic to products from birds—such as feathers, eggs or poultry—or if your leg is swollen or infected. Talk to your doctor before resuming strenuous weight-bearing activities after treatment. Synvisc-One and SYNVISC have not been tested in children, pregnant women or women who are nursing. You should tell your doctor if you think you are pregnant or if you are nursing a child.

View the Important Patient Information for Synvisc-One (PDF) 
View the Important Patient Information for SYNVISC (PDF)